ACRV

ACRIVON THERAPEUTICS INC

ACRV·004890109·US·Common Stock·Healthcare - Biotechnology-Activist

ACRV (ACRIVON THERAPEUTICS INC) is held by 33 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($11.6M), WELLINGTON MANAGEMENT GROUP LLP ($1.2M), RENAISSANCE TECHNOLOGIES LLC ($1.1M). Net institutional sentiment: Mixed.

33
Holders
(2 Elite)
$17.9M
Total Value
45% (33)
Consensus
15 buying - 18 selling
13F: Insider & Congress:
ACRVSmart Money Verdict
View all
Held by 33 funds
2 elite
Who's Trading
ActivistCitadel Securities LLCCitadel Securities LLC0.0%May 15, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.28.8%Apr 23, 2026
InsiderBPBlume-Jensen PeterBuy $82KJan 14, 2026
InsiderLDLevy Adam D.Buy $15KJan 14, 2026
InsiderDEDevroe EricBuy $17KJan 13, 2026
ActivistSLSands Capital Life Sciences Pulse Fund II, L.P.6.8%Aug 13, 2025
ActivistPAPerceptive Advisors LLC0.0%Jun 4, 2025
InsiderPLPERCEPTIVE ADVISORS LLCSell $401KMay 1, 2025
InsiderPLPERCEPTIVE ADVISORS LLCSell $617KApr 30, 2025
InsiderPLPERCEPTIVE ADVISORS LLCSell $353KApr 29, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
8.3M$11.6M0.1%-78.46%
0
Unchanged
888,130$1.2M0.0%-82.99%
0
Increased
758,440(+19.6%)$1.1M0.0%+10.67%
30
New
722,035$1M0.0%+17.37%
38
Increased
560,436(+13.0%)$779,0070.0%-53.46%
28
Decreased
389,395(-33.4%)$541,2590.0%+2.63%
0
Decreased
239,691(-29.9%)$333,1710.0%+40.86%
0
Increased
236,391(+19.3%)$328,6890.0%-75.35%
19
Increased
208,939(+1.9%)$290,4250.0%-63.31%
16
New
107,529$149,4650.0%+17.37%
34
Unchanged
67,145$93,3320.0%-64.74%
0
Increased
66,882(+225.1%)$92,9660.0%+28.49%
35
Decreased
48,902(-23.3%)$67,9730.0%-74.67%
0
Decreased
36,671(-21.7%)$50,9730.0%-52.58%
0
Decreased
34,634(-90.1%)$48,1410.0%+7.52%
0
New
33,814$47,0010.0%+17.37%
28
Increased
27,472(+5.0%)$38,1860.0%+60.34%
14
Increased
20,000(+100.0%)$27,8000.0%-4.62%
31
Unchanged
18,364$25,3560.0%-66.28%
0
Decreased
16,513(-5.3%)$22,9530.0%-63.77%
0

Showing 1-20 of 41

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used